 David Allen
Concepts (456)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Myostatin | 9 | 2011 | 25 | 2.210 |
Why?
| | Muscle, Skeletal | 35 | 2015 | 1724 | 1.990 |
Why?
| | Muscle Fibers, Skeletal | 16 | 2011 | 218 | 1.860 |
Why?
| | Myosin Heavy Chains | 18 | 2011 | 192 | 1.730 |
Why?
| | Antigens, Human Platelet | 7 | 2013 | 9 | 1.380 |
Why?
| | Isoantibodies | 6 | 2013 | 60 | 1.120 |
Why?
| | Food Deprivation | 4 | 2010 | 25 | 1.090 |
Why?
| | Muscular Atrophy | 5 | 2010 | 86 | 1.000 |
Why?
| | Gene Expression Regulation | 11 | 2010 | 2607 | 0.980 |
Why?
| | Muscle Fibers, Fast-Twitch | 7 | 2010 | 17 | 0.900 |
Why?
| | Adaptation, Physiological | 10 | 2011 | 553 | 0.890 |
Why?
| | Physical Conditioning, Animal | 7 | 2020 | 258 | 0.880 |
Why?
| | Promoter Regions, Genetic | 12 | 2010 | 1251 | 0.880 |
Why?
| | Matrix Metalloproteinase 9 | 4 | 2013 | 132 | 0.820 |
Why?
| | Hindlimb | 6 | 2011 | 128 | 0.680 |
Why?
| | Calcineurin | 5 | 2010 | 108 | 0.640 |
Why?
| | Integrin beta3 | 4 | 2013 | 11 | 0.580 |
Why?
| | Transcription, Genetic | 8 | 2020 | 1457 | 0.540 |
Why?
| | Blood Platelets | 3 | 2011 | 408 | 0.540 |
Why?
| | Edetic Acid | 3 | 2013 | 50 | 0.520 |
Why?
| | Thrombocytopenia, Neonatal Alloimmune | 2 | 2013 | 2 | 0.510 |
Why?
| | Myoblasts | 3 | 2008 | 84 | 0.500 |
Why?
| | Hindlimb Suspension | 4 | 2010 | 20 | 0.490 |
Why?
| | Exercise | 4 | 2015 | 2061 | 0.480 |
Why?
| | Mice | 35 | 2011 | 17794 | 0.460 |
Why?
| | RNA, Messenger | 14 | 2010 | 2834 | 0.450 |
Why?
| | Elbow Joint | 2 | 2015 | 71 | 0.450 |
Why?
| | Transforming Growth Factor beta | 3 | 2008 | 483 | 0.440 |
Why?
| | Space Flight | 4 | 2008 | 87 | 0.440 |
Why?
| | Muscle Development | 6 | 2010 | 111 | 0.430 |
Why?
| | Animals | 55 | 2020 | 36951 | 0.430 |
Why?
| | Integrin alpha2 | 1 | 2013 | 3 | 0.410 |
Why?
| | Weightlessness | 4 | 2008 | 45 | 0.410 |
Why?
| | Chelating Agents | 1 | 2013 | 75 | 0.400 |
Why?
| | Platelet Glycoprotein GPIIb-IIIa Complex | 2 | 2011 | 24 | 0.380 |
Why?
| | Iron Chelating Agents | 1 | 2011 | 18 | 0.370 |
Why?
| | Dexamethasone | 2 | 2010 | 370 | 0.360 |
Why?
| | Organ Size | 12 | 2010 | 477 | 0.360 |
Why?
| | Molecular Sequence Data | 10 | 2010 | 2900 | 0.340 |
Why?
| | CCAAT-Enhancer-Binding Protein-delta | 1 | 2010 | 6 | 0.340 |
Why?
| | Tolloid-Like Metalloproteinases | 1 | 2010 | 1 | 0.340 |
Why?
| | Bone Morphogenetic Protein 1 | 1 | 2010 | 1 | 0.340 |
Why?
| | Transcription Factors | 6 | 2020 | 1719 | 0.340 |
Why?
| | Smad Proteins | 2 | 2010 | 42 | 0.340 |
Why?
| | Elbow | 1 | 2011 | 55 | 0.340 |
Why?
| | RNA Processing, Post-Transcriptional | 1 | 2010 | 92 | 0.320 |
Why?
| | Epitopes | 2 | 2011 | 479 | 0.320 |
Why?
| | Mice, Inbred C57BL | 12 | 2011 | 5764 | 0.310 |
Why?
| | Physical Exertion | 5 | 2015 | 215 | 0.300 |
Why?
| | Regulatory Sequences, Nucleic Acid | 2 | 2008 | 91 | 0.290 |
Why?
| | DNA, Intergenic | 1 | 2008 | 26 | 0.290 |
Why?
| | Activin Receptors, Type II | 1 | 2008 | 12 | 0.290 |
Why?
| | Genes, MHC Class II | 1 | 2008 | 74 | 0.290 |
Why?
| | CLOCK Proteins | 2 | 2020 | 8 | 0.280 |
Why?
| | Base Sequence | 7 | 2010 | 2181 | 0.280 |
Why?
| | Protein Isoforms | 7 | 2008 | 404 | 0.280 |
Why?
| | Motor Activity | 7 | 2005 | 718 | 0.280 |
Why?
| | Adipose Tissue | 3 | 2011 | 635 | 0.280 |
Why?
| | Muscle Fibers, Slow-Twitch | 5 | 2010 | 15 | 0.270 |
Why?
| | Genotype | 4 | 2011 | 1917 | 0.260 |
Why?
| | MicroRNAs | 2 | 2010 | 692 | 0.260 |
Why?
| | Antibodies, Monoclonal | 4 | 2011 | 1430 | 0.260 |
Why?
| | Obesity | 2 | 2011 | 2993 | 0.250 |
Why?
| | Transfection | 7 | 2008 | 945 | 0.250 |
Why?
| | Drosophila Proteins | 3 | 2020 | 204 | 0.250 |
Why?
| | Cell Nucleus | 7 | 2001 | 620 | 0.250 |
Why?
| | Brain-Derived Neurotrophic Factor | 1 | 2007 | 131 | 0.240 |
Why?
| | Enzyme-Linked Immunosorbent Assay | 3 | 2013 | 853 | 0.240 |
Why?
| | Forkhead Transcription Factors | 1 | 2006 | 191 | 0.240 |
Why?
| | Calcium Signaling | 2 | 2009 | 249 | 0.240 |
Why?
| | Interleukin-6 | 1 | 2009 | 778 | 0.230 |
Why?
| | Circadian Rhythm | 3 | 2020 | 468 | 0.230 |
Why?
| | Muscular Diseases | 2 | 2011 | 114 | 0.230 |
Why?
| | Purpura, Thrombocytopenic | 1 | 2004 | 4 | 0.230 |
Why?
| | Serum Response Factor | 1 | 2005 | 33 | 0.230 |
Why?
| | Platelet Transfusion | 2 | 2004 | 67 | 0.230 |
Why?
| | Insulin-Like Growth Factor I | 5 | 2003 | 319 | 0.220 |
Why?
| | Growth Hormone | 4 | 1998 | 101 | 0.220 |
Why?
| | DNA-Binding Proteins | 4 | 2009 | 1502 | 0.220 |
Why?
| | Physical Endurance | 2 | 2002 | 275 | 0.210 |
Why?
| | Cells, Cultured | 8 | 2010 | 4193 | 0.210 |
Why?
| | Infant, Newborn, Diseases | 1 | 2004 | 113 | 0.200 |
Why?
| | Polymorphism, Single Nucleotide | 4 | 2011 | 2189 | 0.200 |
Why?
| | Cell Differentiation | 3 | 2010 | 1991 | 0.200 |
Why?
| | Growth Substances | 1 | 2002 | 147 | 0.200 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 3 | 2010 | 976 | 0.190 |
Why?
| | Matrix Metalloproteinases | 1 | 2002 | 95 | 0.190 |
Why?
| | Calcium-Calmodulin-Dependent Protein Kinases | 1 | 2002 | 182 | 0.190 |
Why?
| | Proteins | 1 | 2008 | 1009 | 0.180 |
Why?
| | Stress, Psychological | 1 | 2010 | 1108 | 0.180 |
Why?
| | Rats | 12 | 2011 | 5648 | 0.180 |
Why?
| | Male | 26 | 2022 | 67906 | 0.180 |
Why?
| | Cell Line | 5 | 2010 | 2847 | 0.170 |
Why?
| | Gene Expression Regulation, Developmental | 3 | 2006 | 860 | 0.170 |
Why?
| | Nuclear Proteins | 3 | 2006 | 712 | 0.170 |
Why?
| | Mice, Transgenic | 5 | 2011 | 2167 | 0.170 |
Why?
| | Circadian Clocks | 1 | 2020 | 50 | 0.160 |
Why?
| | Heart | 4 | 2005 | 655 | 0.160 |
Why?
| | Cardiovascular Physiological Phenomena | 1 | 2020 | 42 | 0.160 |
Why?
| | Histone Acetyltransferases | 1 | 2020 | 60 | 0.160 |
Why?
| | Acclimatization | 1 | 2001 | 177 | 0.160 |
Why?
| | Binding Sites | 5 | 2007 | 1303 | 0.160 |
Why?
| | Drosophila | 1 | 2020 | 154 | 0.150 |
Why?
| | Proteomics | 3 | 2020 | 1111 | 0.150 |
Why?
| | Corticosterone | 2 | 2010 | 236 | 0.150 |
Why?
| | Bariatric Surgery | 1 | 2022 | 217 | 0.150 |
Why?
| | Fibronectins | 4 | 2002 | 133 | 0.150 |
Why?
| | Electrophoresis, Polyacrylamide Gel | 7 | 2009 | 345 | 0.150 |
Why?
| | Weight-Bearing | 3 | 2001 | 173 | 0.150 |
Why?
| | Muscle Proteins | 2 | 2010 | 231 | 0.140 |
Why?
| | Mutation | 4 | 2011 | 3959 | 0.140 |
Why?
| | Diabetes Mellitus, Type 2 | 1 | 2011 | 2534 | 0.130 |
Why?
| | Thrombocytopenia | 3 | 2004 | 200 | 0.130 |
Why?
| | Luciferases | 2 | 2008 | 150 | 0.130 |
Why?
| | Calcium | 1 | 2002 | 1200 | 0.130 |
Why?
| | NFATC Transcription Factors | 2 | 2009 | 95 | 0.120 |
Why?
| | Glucocorticoids | 2 | 2010 | 596 | 0.120 |
Why?
| | Protein Binding | 3 | 2020 | 2224 | 0.120 |
Why?
| | Staphylococcus aureus | 2 | 2011 | 450 | 0.120 |
Why?
| | Fluorescent Antibody Technique | 2 | 2009 | 390 | 0.120 |
Why?
| | Mice, Knockout | 5 | 2010 | 3018 | 0.120 |
Why?
| | Humans | 33 | 2022 | 137782 | 0.120 |
Why?
| | Microscopy, Confocal | 6 | 2001 | 325 | 0.110 |
Why?
| | Female | 22 | 2022 | 73465 | 0.110 |
Why?
| | Body Weight | 6 | 2003 | 985 | 0.110 |
Why?
| | Genetic Variation | 4 | 2007 | 991 | 0.110 |
Why?
| | Hypertrophy | 3 | 2001 | 133 | 0.110 |
Why?
| | Signal Transduction | 5 | 2009 | 5081 | 0.110 |
Why?
| | Tissue Inhibitor of Metalloproteinase-1 | 1 | 2013 | 26 | 0.110 |
Why?
| | Mutagenesis, Site-Directed | 2 | 2006 | 375 | 0.100 |
Why?
| | Immunoassay | 1 | 1994 | 115 | 0.100 |
Why?
| | Bacterial Proteins | 2 | 2011 | 879 | 0.100 |
Why?
| | Amino Acid Sequence | 5 | 2009 | 2139 | 0.100 |
Why?
| | Species Specificity | 2 | 2020 | 585 | 0.100 |
Why?
| | Aging | 2 | 2001 | 1865 | 0.100 |
Why?
| | Isometric Contraction | 2 | 2015 | 188 | 0.100 |
Why?
| | Infant, Newborn | 5 | 2013 | 6084 | 0.100 |
Why?
| | Immunity, Maternally-Acquired | 1 | 1992 | 19 | 0.100 |
Why?
| | Range of Motion, Articular | 2 | 2015 | 393 | 0.100 |
Why?
| | Education | 1 | 2013 | 108 | 0.100 |
Why?
| | Vancomycin Resistance | 2 | 2011 | 16 | 0.100 |
Why?
| | Blotting, Western | 3 | 2010 | 1227 | 0.090 |
Why?
| | Apoptosis | 2 | 1999 | 2553 | 0.090 |
Why?
| | Practice Guidelines as Topic | 1 | 2020 | 1586 | 0.090 |
Why?
| | Gluconeogenesis | 2 | 2010 | 79 | 0.090 |
Why?
| | Sensitivity and Specificity | 2 | 2013 | 1946 | 0.090 |
Why?
| | Antigen-Antibody Complex | 1 | 2011 | 90 | 0.090 |
Why?
| | Sequence Homology, Nucleic Acid | 2 | 2008 | 155 | 0.090 |
Why?
| | Time Factors | 3 | 2010 | 6834 | 0.090 |
Why?
| | Drug Resistance, Multiple, Bacterial | 1 | 2011 | 78 | 0.090 |
Why?
| | Weight Loss | 2 | 2022 | 788 | 0.090 |
Why?
| | Rats, Sprague-Dawley | 6 | 2003 | 2487 | 0.090 |
Why?
| | Genes, Bacterial | 2 | 2008 | 164 | 0.090 |
Why?
| | Running | 1 | 2013 | 230 | 0.090 |
Why?
| | Protein Kinase C | 2 | 2002 | 261 | 0.090 |
Why?
| | Muscle Fatigue | 2 | 2011 | 102 | 0.090 |
Why?
| | Torque | 1 | 2011 | 84 | 0.080 |
Why?
| | SKP Cullin F-Box Protein Ligases | 1 | 2010 | 15 | 0.080 |
Why?
| | Glucokinase | 1 | 2010 | 15 | 0.080 |
Why?
| | Phosphoenolpyruvate Carboxykinase (GTP) | 1 | 2010 | 32 | 0.080 |
Why?
| | Quality of Life | 1 | 2022 | 2894 | 0.080 |
Why?
| | Tripartite Motif Proteins | 1 | 2010 | 41 | 0.080 |
Why?
| | 3T3 Cells | 3 | 2008 | 163 | 0.080 |
Why?
| | Mice, Obese | 2 | 2008 | 66 | 0.080 |
Why?
| | DNA | 4 | 2008 | 1459 | 0.080 |
Why?
| | Phosphatidylethanolamine Binding Protein | 1 | 2009 | 1 | 0.080 |
Why?
| | Proteome | 2 | 2007 | 472 | 0.080 |
Why?
| | Oxazolidinones | 1 | 2009 | 15 | 0.080 |
Why?
| | Immunohistochemistry | 5 | 2003 | 1738 | 0.080 |
Why?
| | Thymus Gland | 1 | 2010 | 312 | 0.080 |
Why?
| | Proto-Oncogene Proteins c-akt | 2 | 2008 | 437 | 0.080 |
Why?
| | Ubiquitin-Protein Ligases | 1 | 2010 | 175 | 0.070 |
Why?
| | Body Temperature Regulation | 2 | 2007 | 97 | 0.070 |
Why?
| | Skeletal Muscle Myosins | 1 | 2008 | 2 | 0.070 |
Why?
| | RNA, Antisense | 1 | 2008 | 17 | 0.070 |
Why?
| | Follistatin-Related Proteins | 1 | 2008 | 2 | 0.070 |
Why?
| | Calcium-Binding Proteins | 1 | 2009 | 218 | 0.070 |
Why?
| | Myogenic Regulatory Factors | 2 | 2005 | 57 | 0.070 |
Why?
| | MEF2 Transcription Factors | 2 | 2005 | 61 | 0.070 |
Why?
| | Spleen | 1 | 2010 | 514 | 0.070 |
Why?
| | Models, Animal | 1 | 2009 | 384 | 0.070 |
Why?
| | ADP Ribose Transferases | 1 | 2007 | 9 | 0.070 |
Why?
| | Muscle Contraction | 1 | 2011 | 424 | 0.070 |
Why?
| | Multigene Family | 1 | 2008 | 198 | 0.070 |
Why?
| | Creatine Kinase | 3 | 2015 | 79 | 0.070 |
Why?
| | Eating | 1 | 2010 | 380 | 0.070 |
Why?
| | Analysis of Variance | 1 | 2010 | 1316 | 0.070 |
Why?
| | Adult | 8 | 2022 | 38023 | 0.070 |
Why?
| | Point Mutation | 1 | 2008 | 235 | 0.070 |
Why?
| | Up-Regulation | 1 | 2010 | 843 | 0.070 |
Why?
| | Cluster Analysis | 1 | 2008 | 501 | 0.070 |
Why?
| | Cloning, Molecular | 1 | 2008 | 534 | 0.070 |
Why?
| | Protein Kinases | 1 | 2008 | 319 | 0.060 |
Why?
| | Phosphatidylinositol 3-Kinases | 1 | 2008 | 366 | 0.060 |
Why?
| | Oligonucleotide Array Sequence Analysis | 1 | 2008 | 767 | 0.060 |
Why?
| | Adolescent | 5 | 2022 | 21574 | 0.060 |
Why?
| | Intracellular Signaling Peptides and Proteins | 1 | 2009 | 455 | 0.060 |
Why?
| | Cerebrospinal Fluid | 1 | 2007 | 92 | 0.060 |
Why?
| | Myogenic Regulatory Factor 5 | 1 | 2006 | 7 | 0.060 |
Why?
| | Leptin | 1 | 2008 | 236 | 0.060 |
Why?
| | NF-kappa B | 1 | 2010 | 691 | 0.060 |
Why?
| | Forkhead Box Protein O1 | 1 | 2006 | 33 | 0.060 |
Why?
| | Animals, Newborn | 4 | 2001 | 844 | 0.060 |
Why?
| | MyoD Protein | 1 | 2006 | 35 | 0.060 |
Why?
| | Dietary Fats | 1 | 2008 | 304 | 0.060 |
Why?
| | Feeding Behavior | 2 | 2022 | 655 | 0.060 |
Why?
| | Anti-Inflammatory Agents | 1 | 2009 | 496 | 0.060 |
Why?
| | Statistics as Topic | 1 | 2007 | 307 | 0.060 |
Why?
| | Genes, Reporter | 2 | 2006 | 269 | 0.060 |
Why?
| | Polymerase Chain Reaction | 1 | 2008 | 1063 | 0.060 |
Why?
| | Young Adult | 4 | 2022 | 13240 | 0.060 |
Why?
| | TOR Serine-Threonine Kinases | 1 | 2008 | 412 | 0.060 |
Why?
| | Cattle | 1 | 2008 | 985 | 0.060 |
Why?
| | Octamer Transcription Factor-1 | 1 | 2005 | 5 | 0.060 |
Why?
| | Reproducibility of Results | 2 | 2008 | 3290 | 0.060 |
Why?
| | Mice, Inbred Strains | 2 | 2002 | 409 | 0.060 |
Why?
| | Microspheres | 1 | 2005 | 137 | 0.060 |
Why?
| | Phenotype | 6 | 2007 | 3196 | 0.060 |
Why?
| | Tobacco Use Disorder | 1 | 2007 | 251 | 0.060 |
Why?
| | Myocardium | 3 | 2005 | 1002 | 0.060 |
Why?
| | Gene Expression Regulation, Bacterial | 1 | 2007 | 328 | 0.060 |
Why?
| | Biomarkers | 3 | 2013 | 4154 | 0.060 |
Why?
| | Receptors, Nicotinic | 1 | 2007 | 334 | 0.060 |
Why?
| | Immunoglobulins | 1 | 2005 | 171 | 0.060 |
Why?
| | Tissue Distribution | 1 | 2005 | 332 | 0.050 |
Why?
| | Affect | 1 | 2007 | 292 | 0.050 |
Why?
| | Life Style | 1 | 2007 | 491 | 0.050 |
Why?
| | Oligonucleotides | 1 | 2005 | 148 | 0.050 |
Why?
| | Plasmids | 1 | 2005 | 363 | 0.050 |
Why?
| | Drosophila melanogaster | 2 | 2014 | 233 | 0.050 |
Why?
| | Cell Count | 3 | 2002 | 324 | 0.050 |
Why?
| | Desmin | 1 | 2003 | 24 | 0.050 |
Why?
| | Blood Proteins | 1 | 2005 | 252 | 0.050 |
Why?
| | Green Fluorescent Proteins | 1 | 2005 | 390 | 0.050 |
Why?
| | Gene Deletion | 1 | 2005 | 391 | 0.050 |
Why?
| | Peptide Fragments | 2 | 2000 | 706 | 0.050 |
Why?
| | Matrix Metalloproteinase 1 | 1 | 2002 | 22 | 0.050 |
Why?
| | Calcimycin | 1 | 2002 | 49 | 0.050 |
Why?
| | Transcriptional Activation | 1 | 2005 | 378 | 0.050 |
Why?
| | Ionophores | 1 | 2002 | 24 | 0.050 |
Why?
| | Liver | 1 | 2011 | 1943 | 0.050 |
Why?
| | Matrix Metalloproteinase 2 | 1 | 2002 | 56 | 0.050 |
Why?
| | Gene Expression | 4 | 2020 | 1502 | 0.050 |
Why?
| | Heart Rate | 1 | 2007 | 824 | 0.050 |
Why?
| | Gene Transfer Techniques | 2 | 2003 | 171 | 0.050 |
Why?
| | Enhancer Elements, Genetic | 2 | 2001 | 190 | 0.050 |
Why?
| | Fibroblast Growth Factor 2 | 1 | 2002 | 87 | 0.050 |
Why?
| | Protein Structure, Tertiary | 1 | 2005 | 861 | 0.050 |
Why?
| | Tumor Necrosis Factor-alpha | 2 | 2009 | 1242 | 0.050 |
Why?
| | Calcineurin Inhibitors | 1 | 2002 | 73 | 0.050 |
Why?
| | Platelet Membrane Glycoproteins | 1 | 2002 | 36 | 0.050 |
Why?
| | Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 3 | 2009 | 144 | 0.050 |
Why?
| | Molecular Biology | 1 | 2002 | 59 | 0.050 |
Why?
| | Motivation | 1 | 2007 | 570 | 0.050 |
Why?
| | Mice, SCID | 1 | 2002 | 367 | 0.050 |
Why?
| | Cost-Benefit Analysis | 1 | 2004 | 593 | 0.050 |
Why?
| | Antibodies | 1 | 2004 | 410 | 0.050 |
Why?
| | Selection, Genetic | 1 | 1984 | 274 | 0.050 |
Why?
| | Brain Injuries | 1 | 2007 | 494 | 0.050 |
Why?
| | NADH Tetrazolium Reductase | 1 | 2001 | 2 | 0.050 |
Why?
| | Cytokines | 1 | 2009 | 2085 | 0.050 |
Why?
| | Gene Expression Profiling | 1 | 2008 | 1775 | 0.050 |
Why?
| | Isoenzymes | 1 | 2002 | 304 | 0.040 |
Why?
| | Phosphorylation | 3 | 2014 | 1759 | 0.040 |
Why?
| | Anti-Bacterial Agents | 1 | 2011 | 1809 | 0.040 |
Why?
| | Gravitation | 1 | 2001 | 18 | 0.040 |
Why?
| | T-Lymphocytes | 1 | 2009 | 1998 | 0.040 |
Why?
| | Mitogen-Activated Protein Kinases | 1 | 2002 | 313 | 0.040 |
Why?
| | Child Abuse | 1 | 2007 | 537 | 0.040 |
Why?
| | Cell Movement | 2 | 2002 | 967 | 0.040 |
Why?
| | Electrophoresis, Gel, Two-Dimensional | 3 | 2007 | 114 | 0.040 |
Why?
| | Sarcomeres | 1 | 2001 | 96 | 0.040 |
Why?
| | Homozygote | 1 | 2001 | 203 | 0.040 |
Why?
| | Chemotactic Factors | 1 | 2000 | 56 | 0.040 |
Why?
| | MAP Kinase Signaling System | 1 | 2002 | 320 | 0.040 |
Why?
| | Animal Care Committees | 1 | 2020 | 6 | 0.040 |
Why?
| | Blood Glucose | 1 | 2010 | 2190 | 0.040 |
Why?
| | Factor IX | 1 | 2000 | 48 | 0.040 |
Why?
| | Diet | 1 | 2008 | 1279 | 0.040 |
Why?
| | Heterozygote | 1 | 2001 | 293 | 0.040 |
Why?
| | Antigen-Antibody Reactions | 2 | 2002 | 55 | 0.040 |
Why?
| | Dependovirus | 1 | 2000 | 68 | 0.040 |
Why?
| | Propionates | 1 | 1999 | 39 | 0.040 |
Why?
| | Transgenes | 1 | 2000 | 180 | 0.040 |
Why?
| | Reference Values | 1 | 2001 | 816 | 0.040 |
Why?
| | Myosins | 2 | 2000 | 135 | 0.040 |
Why?
| | Antigens, CD | 1 | 2002 | 521 | 0.040 |
Why?
| | Enzyme Inhibitors | 1 | 2002 | 840 | 0.040 |
Why?
| | RNA Interference | 1 | 2020 | 469 | 0.040 |
Why?
| | Genetic Vectors | 1 | 2000 | 319 | 0.040 |
Why?
| | Period Circadian Proteins | 2 | 2014 | 16 | 0.040 |
Why?
| | Flow Cytometry | 2 | 2009 | 1178 | 0.040 |
Why?
| | Oligopeptides | 1 | 2000 | 271 | 0.040 |
Why?
| | Cats | 2 | 1995 | 210 | 0.040 |
Why?
| | Genes, Insect | 1 | 1997 | 22 | 0.030 |
Why?
| | Wound Healing | 1 | 2000 | 331 | 0.030 |
Why?
| | Sequence Homology, Amino Acid | 2 | 2008 | 385 | 0.030 |
Why?
| | Alcoholism | 1 | 1984 | 809 | 0.030 |
Why?
| | Cytoplasm | 1 | 1997 | 274 | 0.030 |
Why?
| | Cell Wall | 2 | 2011 | 54 | 0.030 |
Why?
| | Recombinant Proteins | 2 | 1997 | 1356 | 0.030 |
Why?
| | DNA, Bacterial | 2 | 2008 | 337 | 0.030 |
Why?
| | Extracellular Matrix | 1 | 2000 | 528 | 0.030 |
Why?
| | Myalgia | 1 | 2015 | 13 | 0.030 |
Why?
| | Visual Analog Scale | 1 | 2015 | 33 | 0.030 |
Why?
| | Chromatography, Liquid | 2 | 2009 | 433 | 0.030 |
Why?
| | Decerebrate State | 1 | 1995 | 3 | 0.030 |
Why?
| | Myosin Subfragments | 1 | 1995 | 22 | 0.030 |
Why?
| | Staphylococcal Infections | 2 | 2011 | 400 | 0.030 |
Why?
| | Escherichia coli | 1 | 1999 | 815 | 0.030 |
Why?
| | Atrophy | 1 | 1995 | 184 | 0.030 |
Why?
| | Isoantigens | 1 | 1994 | 15 | 0.030 |
Why?
| | ARNTL Transcription Factors | 1 | 2014 | 17 | 0.030 |
Why?
| | Antibody Specificity | 1 | 1994 | 189 | 0.030 |
Why?
| | Receptors, Somatotropin | 1 | 1993 | 9 | 0.030 |
Why?
| | United Kingdom | 1 | 1994 | 318 | 0.030 |
Why?
| | Coombs Test | 1 | 1992 | 5 | 0.030 |
Why?
| | Immunosorbent Techniques | 1 | 1992 | 21 | 0.030 |
Why?
| | Volition | 2 | 2003 | 34 | 0.020 |
Why?
| | Histocompatibility Testing | 1 | 1992 | 126 | 0.020 |
Why?
| | Mass Spectrometry | 2 | 2007 | 739 | 0.020 |
Why?
| | Citrate (si)-Synthase | 2 | 2003 | 60 | 0.020 |
Why?
| | Pregnancy | 3 | 1992 | 6771 | 0.020 |
Why?
| | Prostatic Neoplasms | 1 | 2000 | 1043 | 0.020 |
Why?
| | Molecular Typing | 1 | 2011 | 22 | 0.020 |
Why?
| | Daptomycin | 1 | 2011 | 18 | 0.020 |
Why?
| | Sequence Analysis, DNA | 2 | 2007 | 812 | 0.020 |
Why?
| | Leg | 1 | 2013 | 236 | 0.020 |
Why?
| | Diabetes Mellitus | 1 | 2000 | 1041 | 0.020 |
Why?
| | Rh Isoimmunization | 1 | 1991 | 3 | 0.020 |
Why?
| | HLA Antigens | 1 | 1992 | 240 | 0.020 |
Why?
| | Rh-Hr Blood-Group System | 1 | 1991 | 12 | 0.020 |
Why?
| | Abnormalities, Multiple | 1 | 1992 | 189 | 0.020 |
Why?
| | Vancomycin | 1 | 2011 | 84 | 0.020 |
Why?
| | Cell Cycle | 1 | 1993 | 601 | 0.020 |
Why?
| | Muscle Strength | 1 | 2013 | 322 | 0.020 |
Why?
| | Receptors, Fibronectin | 2 | 2000 | 6 | 0.020 |
Why?
| | Microbial Sensitivity Tests | 1 | 2011 | 361 | 0.020 |
Why?
| | Virulence Factors | 1 | 2011 | 167 | 0.020 |
Why?
| | Surveys and Questionnaires | 1 | 2022 | 5793 | 0.020 |
Why?
| | Clonal Anergy | 1 | 2009 | 52 | 0.020 |
Why?
| | Disease Models, Animal | 1 | 2020 | 4295 | 0.020 |
Why?
| | Rats, Wistar | 2 | 2001 | 455 | 0.020 |
Why?
| | Biofilms | 1 | 2011 | 261 | 0.020 |
Why?
| | Extracellular Signal-Regulated MAP Kinases | 1 | 2009 | 171 | 0.020 |
Why?
| | Oxidation-Reduction | 2 | 2003 | 1060 | 0.020 |
Why?
| | Predictive Value of Tests | 1 | 1994 | 2041 | 0.020 |
Why?
| | Antineoplastic Agents | 1 | 2000 | 2129 | 0.020 |
Why?
| | Kinetics | 3 | 2000 | 1670 | 0.020 |
Why?
| | High-Throughput Nucleotide Sequencing | 1 | 2011 | 539 | 0.020 |
Why?
| | Genetic Complementation Test | 1 | 2007 | 67 | 0.020 |
Why?
| | Genes, Regulator | 1 | 2007 | 37 | 0.020 |
Why?
| | Administration, Cutaneous | 1 | 2007 | 130 | 0.020 |
Why?
| | DNA Primers | 1 | 2008 | 516 | 0.020 |
Why?
| | Cystatins | 1 | 2007 | 7 | 0.020 |
Why?
| | Sequence Deletion | 1 | 2007 | 183 | 0.020 |
Why?
| | Lipocalins | 1 | 2007 | 36 | 0.020 |
Why?
| | Cystatin C | 1 | 2007 | 65 | 0.020 |
Why?
| | Intramolecular Oxidoreductases | 1 | 2007 | 68 | 0.020 |
Why?
| | Haptoglobins | 1 | 2007 | 53 | 0.020 |
Why?
| | Gas Chromatography-Mass Spectrometry | 1 | 2007 | 132 | 0.020 |
Why?
| | Tandem Mass Spectrometry | 1 | 2009 | 532 | 0.020 |
Why?
| | Fibroblasts | 2 | 2003 | 996 | 0.020 |
Why?
| | Lung Neoplasms | 1 | 2000 | 2526 | 0.020 |
Why?
| | Immunoblotting | 1 | 2007 | 308 | 0.020 |
Why?
| | Smoking Prevention | 1 | 2007 | 184 | 0.020 |
Why?
| | Nucleus Accumbens | 1 | 2007 | 138 | 0.020 |
Why?
| | Lymphocyte Activation | 1 | 2009 | 1142 | 0.010 |
Why?
| | Cell Division | 2 | 2000 | 794 | 0.010 |
Why?
| | Ribosomal Protein S6 Kinases, 70-kDa | 1 | 2005 | 35 | 0.010 |
Why?
| | Glycogen Synthase Kinase 3 beta | 1 | 2005 | 72 | 0.010 |
Why?
| | Albumins | 1 | 2005 | 114 | 0.010 |
Why?
| | Nicotine | 1 | 2007 | 334 | 0.010 |
Why?
| | Glycogen Synthase Kinase 3 | 1 | 2005 | 82 | 0.010 |
Why?
| | Alcohol Withdrawal Delirium | 1 | 1984 | 8 | 0.010 |
Why?
| | Genes, Dominant | 1 | 1984 | 96 | 0.010 |
Why?
| | Purpura | 1 | 2004 | 17 | 0.010 |
Why?
| | Exploratory Behavior | 1 | 1984 | 92 | 0.010 |
Why?
| | Isomerism | 1 | 2003 | 56 | 0.010 |
Why?
| | Smoking Cessation | 1 | 2007 | 442 | 0.010 |
Why?
| | Muscle Cells | 1 | 2003 | 43 | 0.010 |
Why?
| | Motor Skills | 1 | 1984 | 97 | 0.010 |
Why?
| | Genomics | 1 | 2008 | 795 | 0.010 |
Why?
| | Protein Kinase C-epsilon | 1 | 2002 | 25 | 0.010 |
Why?
| | Peptide Mapping | 1 | 2002 | 64 | 0.010 |
Why?
| | Epitopes, B-Lymphocyte | 1 | 2002 | 17 | 0.010 |
Why?
| | RNA Precursors | 1 | 2003 | 154 | 0.010 |
Why?
| | CHO Cells | 1 | 2002 | 161 | 0.010 |
Why?
| | Cricetinae | 1 | 2002 | 289 | 0.010 |
Why?
| | Coloring Agents | 1 | 2002 | 87 | 0.010 |
Why?
| | Proto-Oncogene Proteins | 1 | 2005 | 648 | 0.010 |
Why?
| | Electrophoresis | 1 | 2001 | 32 | 0.010 |
Why?
| | Amino Acid Substitution | 1 | 2002 | 307 | 0.010 |
Why?
| | Animals, Suckling | 1 | 2000 | 10 | 0.010 |
Why?
| | Fatigue | 1 | 2002 | 329 | 0.010 |
Why?
| | Seizures | 1 | 1984 | 426 | 0.010 |
Why?
| | Blotting, Southern | 1 | 2000 | 73 | 0.010 |
Why?
| | In Vitro Techniques | 1 | 2002 | 1092 | 0.010 |
Why?
| | Basement Membrane | 1 | 2000 | 36 | 0.010 |
Why?
| | Chromatography, High Pressure Liquid | 1 | 2002 | 597 | 0.010 |
Why?
| | Embryonic and Fetal Development | 1 | 1999 | 97 | 0.010 |
Why?
| | Autoimmune Diseases | 1 | 2004 | 460 | 0.010 |
Why?
| | Smoking | 1 | 2007 | 1627 | 0.010 |
Why?
| | Putrescine | 1 | 1999 | 2 | 0.010 |
Why?
| | Oxaloacetic Acid | 1 | 1999 | 4 | 0.010 |
Why?
| | Virion | 1 | 2000 | 93 | 0.010 |
Why?
| | Acyl Coenzyme A | 1 | 1999 | 31 | 0.010 |
Why?
| | Formates | 1 | 1999 | 13 | 0.010 |
Why?
| | Protein Biosynthesis | 1 | 2002 | 433 | 0.010 |
Why?
| | Citrates | 1 | 1999 | 44 | 0.010 |
Why?
| | Methylmalonic Acid | 1 | 1999 | 65 | 0.010 |
Why?
| | Citric Acid Cycle | 1 | 1999 | 57 | 0.010 |
Why?
| | Succinic Acid | 1 | 1999 | 37 | 0.010 |
Why?
| | Trehalose | 1 | 1999 | 32 | 0.010 |
Why?
| | Citric Acid | 1 | 1999 | 33 | 0.010 |
Why?
| | Chemotaxis | 1 | 2000 | 131 | 0.010 |
Why?
| | In Situ Hybridization | 1 | 1999 | 316 | 0.010 |
Why?
| | Echocardiography | 1 | 2002 | 644 | 0.010 |
Why?
| | Pyruvic Acid | 1 | 1999 | 53 | 0.010 |
Why?
| | DNA, Single-Stranded | 1 | 2000 | 118 | 0.010 |
Why?
| | Keratinocytes | 1 | 2000 | 249 | 0.010 |
Why?
| | Protons | 1 | 1999 | 89 | 0.010 |
Why?
| | Carbon Isotopes | 1 | 1999 | 144 | 0.010 |
Why?
| | Structure-Activity Relationship | 1 | 2000 | 570 | 0.010 |
Why?
| | Alanine | 1 | 1999 | 152 | 0.010 |
Why?
| | Glycine | 1 | 1999 | 176 | 0.010 |
Why?
| | Neoplasm Invasiveness | 1 | 2000 | 512 | 0.010 |
Why?
| | Tumor Cells, Cultured | 1 | 2000 | 955 | 0.010 |
Why?
| | DNA, Viral | 1 | 2000 | 364 | 0.010 |
Why?
| | Sex Factors | 1 | 1984 | 2077 | 0.010 |
Why?
| | Neoplasm Metastasis | 1 | 2000 | 658 | 0.010 |
Why?
| | Glutamic Acid | 1 | 1999 | 246 | 0.010 |
Why?
| | Hemodynamics | 1 | 2002 | 1113 | 0.010 |
Why?
| | Feedback | 1 | 1997 | 173 | 0.010 |
Why?
| | Magnetic Resonance Spectroscopy | 1 | 1999 | 611 | 0.010 |
Why?
| | Cell Survival | 1 | 2000 | 1120 | 0.010 |
Why?
| | Exercise Test | 1 | 1999 | 632 | 0.010 |
Why?
| | Brain | 1 | 2007 | 2677 | 0.010 |
Why?
| | Succinate Dehydrogenase | 1 | 1995 | 50 | 0.010 |
Why?
| | Thymidine | 1 | 1993 | 60 | 0.010 |
Why?
| | Mass Screening | 1 | 2002 | 1288 | 0.010 |
Why?
| | Age Factors | 1 | 2001 | 3305 | 0.010 |
Why?
| | Infant | 1 | 2007 | 9482 | 0.010 |
Why?
| | Treatment Outcome | 1 | 2007 | 10837 | 0.010 |
Why?
| | Glycerolphosphate Dehydrogenase | 1 | 1992 | 6 | 0.010 |
Why?
| | Insulin | 2 | 1993 | 2411 | 0.010 |
Why?
| | Child, Preschool | 1 | 2007 | 11105 | 0.010 |
Why?
| | Adipocytes | 1 | 1993 | 222 | 0.010 |
Why?
| | Biomechanical Phenomena | 1 | 1995 | 811 | 0.010 |
Why?
| | England | 1 | 1991 | 97 | 0.010 |
Why?
| | Collagen | 1 | 1992 | 452 | 0.000 |
Why?
| | Fetal Blood | 1 | 1991 | 327 | 0.000 |
Why?
| | Pregnancy Outcome | 1 | 1991 | 416 | 0.000 |
Why?
| | Middle Aged | 1 | 2007 | 33554 | 0.000 |
Why?
| | Incidence | 1 | 1991 | 2804 | 0.000 |
Why?
| | Retrospective Studies | 1 | 1991 | 15682 | 0.000 |
Why?
|
|
Allen's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|